S. Louise Phanstiel - Jun 2, 2022 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Director
Signature
By: Nathan A. Smith For: S. Louise Phanstiel
Stock symbol
MYGN
Transactions as of
Jun 2, 2022
Transactions value $
$0
Form type
4
Date filed
6/3/2022, 05:27 PM
Previous filing
Jan 26, 2022
Next filing
Jun 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Award $0 +17.3K +21.72% $0.00 96.8K Jun 2, 2022 Direct F1
holding MYGN Common Stock 33.1K Jun 2, 2022 The Phanstiel Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the Date of Grant and (b) the date of the next annual meeting of stockholders following such grant.